Canada

Synonyms: 
canadian
canuck
ontario
newfoundland
PEI
nova scotia
new brunswick
quebec
manitoba
sasketchewan
alberta
BC
Wed
09
Jan

The top 10 Canadian marijuana stocks of 2018

Marijuana stocks have ebbed and flowed for a few years now, but the absolute peak of the frenzy hit about this time last year. That made the prospect of a year-end list a tough proposition. How bad was it? Of the scores of cannabis related issuers listed in Canada just eight had a positive return in 2018.

You heard that right. Eight.

The culprit, of course, was a year end swoon in global markets that wreaked havoc on most every sector and gutted this one.

A survey taken in early October, for instance, would have produced dozens of winners. But that, as they say, is why you play until the final buzzer. We bring you the top ten Canadian-listed marijuana stocks of 2018.

Wed
09
Jan

Canada's cannabis laws and 5 burning questions for 2019

2018 was a momentous year for cannabis advocates as Canada became the second country (after Uruguay) to legalize recreational marijuana use. Canadians and cannabis companies alike eagerly awaited legalization, but the rollout hasn’t been as smooth as they would have liked.

Wed
09
Jan

Could Canopy Growth Corp (TSX:WEED) stock hit $100 in 2019?

Canopy Growth Corp  (TSX:WEED)(NYSE:CGC) is Canada’s best-known marijuana stock. But in terms of financial results, it’s been far from the best performer. While competitors like Aurora Cannabis Inc have it beat on growth, others, such as CannTrust Holdings have achieved operating profits faster. Nevertheless, Canopy is still the #1 cannabis stock in terms of pure revenue: its sales surpassed Aurora’s by over $20,000,000 in its most recent quarter.

Wed
09
Jan

A weed-tech startup backed by an early Juul investor and Canopy Growth just raised $12 million

Headset, an analytics startup for the nascent marijuana industry, closed a $12.1 million Series A funding round backed by prominent investors.

The round was led by Poseidon Asset Management, an early Juul investor that's raising a $75 million venture fund to go after marijuana startups, and included middle-market private-equity fund AFI Capital Partners and Canopy Rivers, the venture arm of the publicly traded marijuana cultivator Canopy Growth.

Wed
09
Jan

Will cannabis-infused beverage stocks live up to the hype or fizzle out?

If any investors had been wondering how long it would take for the marijuana industry to shed its moniker as "taboo" and become a legitimate business model, wonder no longer.

Last year was a game changer in many ways for the cannabis industry. Canada became the first industrialized country to legalize adult-use weed, the U.S. Food and Drug Administration approved its first cannabis-derived drug, and President Trump signed the Farm Bill into law, legalizing hemp and hemp-based cannabidiol (CBD). Any doubts about marijuana being a valid business model were tossed out the window.

Wed
09
Jan

Shoppers Drug Mart starts selling medical marijuana online

Shoppers Drug Mart's e-commerce platform for medical cannabis launched Tuesday, a month after Health Canada licenced the company to sell the product online.

Product information is available nationally, but Shoppers Drug Mart can initially only sell medical cannabis to patients in Ontario. Patients will be required to take a medical document similar to a prescription to an Ontario pharmacy to begin the process. Specialized advisers will then contact patients, review their medical history and provide support with online registration and product selection.

Shoppers Drug Mart says it has signed supply agreements with 10 licensed producers of dried cannabis and cannabis oil and will provide products and medical accessories.

Wed
09
Jan

3 cannabis stocks with upbeat 2019 revenue guidance

Acreage Holdings and Organigram are some of the few cannabis companies to release 2019 revenue guidance. Given the early stage of the cannabis industry, companies often do not provide revenue & EBITDA outlooks, likely due to speculation. The cannabis stocks on our list have provided revenue estimates for 2019, which give investors and analysts an expectation to follow.

Tue
08
Jan

Canadian airlines is instructing passengers how to fly with cannabis

Last year, Transport Canada revealed that airplane travelers will be allowed to fly with cannabis in their cargo.

This, of course, included a few stipulations. Among them: carry-on rules still apply for liquids, Canadians must be traveling to a domestic destination, and they couldn’t exceed 30 grams of cannabis on their person, which is the legal amount for personal use in Canada anyways.

But now, WestJet is giving Twitter recommendations to its Canadian passengers on how to fly with weed. WestJet is the second-largest Canadian airline carrier with service also extending to the United States, Europe, Central America, and beyond. Still, it’s rather odd to witness a major airline instructing passengers how to pack their stash properly.

Tue
08
Jan

U.S. surgeon general suggests making it easier for researchers to get marijuana

The United States should take a look at some of the restrictions it places on marijuana, according to the country’s top doctor.

Speaking last month at a law enforcement conference at Harvard University in Boston, Surgeon General Jerome Adams was asked about his views on the scheduling system which classifies drugs in the U.S.

“We need to look at our health laws, rules and regulations, and that includes the scheduling system. I’ll take it somewhere else – marijuana,” he said.

“We need to look at the way we schedule different medications across the board. One of the concerns I have with marijuana is the difficulty folks have to do research on it because of the scheduling system.”

Tue
08
Jan

In 2019, focus in cannabis sector shifts from legalization to legitimacy

After a wild year for the cannabis sector, it’s appropriate that 2019 kicks off with a focus on Aphria Inc., the Canadian pot producer that was attacked by short sellers and is now the target of a hostile takeover bid.

Aphria reports results for the fiscal second quarter on Jan. 11, and there will undoubtedly be plenty of questions on the conference call about the allegations from short sellers that it overpaid for “worthless” assets in Latin America. Aphria called the claims by Quintessential Capital Management and Hindenburg Research “malicious and self-serving.”

Pages

Subscribe to RSS - Canada